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ABSTRACT 
Inflammation plays an important role in cerebral ischemic injury in the 
immature brain. The aim of the thesis was to investigate (1) the role of 
astrocyte activation and reactive gliosis in neonatal hypoxic-ischemic (HI) 
brain injury, (2) the role of complement derived peptide C3a in neonatal HI 
brain injury, (3) the effect of neonatal HI brain injury on fear learning and 
behaviour and (4) the effects of lipopolysaccharide (LPS) induced systemic 
inflammation on cell proliferation in the developing brain. Glial fibrillary acidic 
protein and vimentine deficient (GFAP–/–Vim–/–) mice, transgenic mice over-
expressing C3a under the control of a GFAP promoter (C3a/GFAP) and wild 
type mice were exposed to HI at postnatal day 9 (P9). To induce unilateral HI, 
the left common carotid artery was permanently ligated followed by exposure 
to a gas mixture of low oxygen content. Bromodeoxyuridine (BrdU) was 
injected intraperitoneally (i.p.) to detect cell proliferation. Memory was tested 
in mice exposed to HI by using a trace fear conditioning test. We found no 
difference in the hemisphere or infarct volume between GFAP–/–Vim–/– and 
wild-type mice 3 and 22 days after HI. However at P31, GFAP–/–Vim–/– mice 
showed an increase in NeuN+BrdU+ (surviving newly born) neurons in the 
ischemic cortex compared to wild-type. C3a/GFAP mice had reduced loss of 
hippocampal volume in the ipsilateral compared to the contralateral 
hemisphere and a higher hippocampus/hemisphere ratio compared to the WT 
in the ipsilateral hemisphere. C3a/GFAP mice showed a higher number of 
newly born and surviving neurons, astrocytes and microglia in the dentate 
gyrus in the ischemic hemisphere compared to the wild type mice. However, a 
reduced number of astrocytes and microglial cells were found in the C3a/GFAP 
mice in the ipsilateral hemisphere compared to wild-type mice. C3a mRNA 
expression increased in the ipsilateral subventricular zone, hippocampus and 
cortex in C3a/GFAP and wild-type neonatal mice between 0 to 6 hours after HI 
as shown with real time-PCR. Injection of C3a peptide into the ipsilateral 
cerebral ventricle, in wild-type mice, 1 hour after HI, improved memory 
function. The trace fear conditioning test with a shock-paired tone and light 
showed that the control mice remembered the shock-paired context and the 
shock-paired light and tone while HI treated mice did not. The volume of the 
ipsilateral hippocampus and the amygdala was reduced in wild-type mice 
exposed to HI. Wild type mice injected i.p. with LPS on P9 and evaluated at 
P40 showed that LPS reduces cell proliferation and survival of neurons and 
astrocytes in the developing brain. 
Conclusion: Reactive gliosis and LPS-induced systemic inflammation have 
negative effects on neurogenesis and cell proliferation; whereas the 
complement derived peptide C3a improves the outcome after neonatal HI. 
Early targeting treatments that increase cell survival may be important after 
neonatal HI and C3a could be such a potential therapeutic target in the future. 
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MMP Matrix metalloproteinase 
mRNA messenger RNA 
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NGF Nerve growth factor 
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ROS Reactive oxygen species 
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S.E.M Standard error of the mean 
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TBS Tris buffered saline 
TLR Toll-like receptor 
TNF Tumour necrosis factor 
US Unconditional stimulus 
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INTRODUCTION 
Clinical background 
Perinatal hypoxic-ischemic (HI) brain injury can result in a number of 
neurological disorders such as cerebral palsy (CP), mental retardation, 
learning disabilities and epilepsy (Johnston et al., 2001). The risk of developing 
perinatal brain injury is about 2 in 1000 live births in term infants but much 
higher in preterm infants, up to 50% (Himmelmann et al., 2010; Levene et al., 
1985; Thornberg et al., 1995). HI can occur for different reasons before, during 
or after birth. Compression of the umbilical cord or problems with the maternal 
health or placenta can lead to HI. In particular the newborn preterm infant 
might also suffer from circulatory or respiratory problems after birth that lead 
to HI. HI in preterm infants causes predominately white matter injury while 
term infants suffering from HI more often develop injuries in both grey and 
white matter (Volpe, 2008). At present there are no effective therapies to repair 
the brain once it has been injured. More research is necessary to find 
regenerative therapeutic strategies that can assist the recovery of the 
developing brain injury after HI.  
Mechanisms of hypoxic-ischemic perinatal brain injury 
HI brain injury develops through two stages (McLean and Ferriero, 2004; 
Perlman, 2006; Volpe, 2008) and the process continues over time (Nakajima et 
al., 2000). The first stage in the development of HI injury, primary injury, 
affects the local area where energy depletion is acute and leads to necrosis of 
the cells (Northington et al., 2001; Volpe, 2008). The second stage occurs during 
reperfusion, when the blood flow is restored to the brain and secondary energy 
depletion occurs, which leads to inflammation and apoptotic cell death 
(Azzopardi and Edwards, 1995; Lorek et al., 1994).  
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Primary injury 
HI causes an acute lack of oxygen and glucose which leads to cellular energy 
depletion. Extensive energy depletion causes cell necrosis, while less adenosine 
triphosphate (ATP) depletion may not kill the cells immediately but induce 
delayed cell death mechanisms such as apoptosis (Skulachev, 2006; Volpe, 
2008). As the ATP formation decreases, the Na+/K+ -pump is unable to support 
the resting-potential over the membrane which causes depolarisation of the 
neurons and a release of glutamate (Volpe, 2008). Extracellular accumulation 
of the excitotoxic amino acid glutamate will occur (Hagberg et al., 1987). 
Glutamate will bind to ionotropic N-metyl-D-aspartate (NMDA), α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPA), kainate receptors and  
metabotropic glutamate receptors (mGluR) (Degos et al., 2008; Johnston et al., 
2002; Volpe, 2008) that will trigger excessive calcium influx and the formation 
of potentially damaging molecules such as reactive oxygen species (ROS), nitric 
oxide (NO), nitric oxide synthase (NOS), xanthine oxidase and phospholipase A 
(Blomgren and Hagberg, 2006; Ferriero, 2004). This process can lead to 
immediate necrotic cell death with an injury area determined by the severity of 
the initial insult (Blomgren et al., 2003; Skulachev, 2006; Volpe, 2008). 
Secondary injury and secondary energy failure 
When blood flow is restored following HI, a secondary stage of injury occurs. 
Reperfusion normalizes the oxygen and glucose levels, the intracellular pH and 
cell metabolism. However, mitochondrial respiration does not completely 
recover and 4-24 hours later a secondary energy failure occurs, causing 
glutamate release, formation of reactive oxygen species and nitric oxide. 
Inflammatory cells such as macrophages, neutrophils and microglia become 
activated and release pro-inflammatory mediators that can amplify 
inflammation. Resident microglia migrate and proliferate and macrophages 
and neutrophils infiltrate the injured area in the brain (Alvarez-Diaz et al., 
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2007; Bona et al., 1999; Degos et al., 2008; Denker et al., 2007; Hudome et al., 
1997; McRae et al., 1995).  
Cell death 
Cell death mechanisms are often divided into necrosis and apoptosis. Necrosis 
occurs by rupture of the nuclear, mitochondrial or cell membrane due to 
swelling of the cytoplasm and organelles. Excitotoxicity or HI can also activate 
apoptosis or programmed cell death through two major pathways; the caspase-
independent apoptosis-inducing factor (AIF) pathway and the caspase-
dependent (intrinsic and extrinsic) pathway. The caspase-independent and 
caspase-dependent pathway are more important than the necrotic pathway in 
immature brain compared to adult brain (Blomgren and Hagberg, 2006). The 
caspase-independent pathway starts by translocation of AIF from the 
mitochondria to the nucleus and inducing chromatinolysis and DNA 
fragmentation (Blomgren et al., 2003; Hagberg, 2004; Kroemer and Martin, 
2005). The intrinsic caspase-dependent pathway is activated through 
mitochondrial outer membrane permeabilization that leads to cytochrome C 
release. Cytochrome C activates apoptosome assembly in addition to caspase-9 
and caspase-3 activation. The extrinsic caspase-dependent pathway is initiated 
by activation of cell death receptor Fas or tumour necrosis factor-α (TNF-α) on 
the cell surface. The activation of these receptors leads to activation of caspase-
8, which directly activates caspase-3, the final initiating molecule of 
programmed cell death.  
Inflammation 
Inflammation can be triggered by trauma, ischemia or infection and causes 
symptoms such as redness, swelling, pain, and heat in the affected tissue. 
Inflammation is normally a healthy response that helps the body to eliminate 
pathogens and activate tissue regeneration and recovery. However when the 
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inflammation process is unregulated and becomes excessive or chronic it can 
cause tissue damage and impair recovery.   
Inflammation in the brain  
The inflammatory process after HI involves production of inflammatory 
mediators such as cytokines, chemokines, reactive oxygen species (ROS) and 
matrix metalloproteinases (MMPs) through activation of inflammatory cells. 
Up-regulation of the pro-inflammatory cytokines interleukin (IL) 1β, IL-18 and 
TNF-α play an important role in the development of HI injury in the immature 
rodent brain (Aly et al., 2006; Hagberg et al., 1996; Hedtjarn et al., 2002; 
Szaflarski et al., 1995). In addition, anti-inflammatory cytokines and 
neurotrophic factors are released. The relative balance between these pro- and 
anti-inflammatory mediators is likely to be very important for the development 
of the injury (Kriz, 2006). Systemic infection induced by lipopolysaccharide 
(LPS), a bacterial cell wall component, causes inflammation in the brain 
(Eklind et al., 2006), and clinically, intrauterine infection is a risk factor for 
white matter injury and developing CP in the preterm infant (Back, 2006; Wu 
et al., 2003).  
Cells involved in inflammation 
Microglial cells are resident macrophages in the brain that modulate 
inflammation, regulate homeostasis and nerve growth. They are found more 
abundantly in grey matter than in white matter in the adult brain, and 
depending on the degree of activation they change their phenotype (Kim and de 
Vellis, 2005; Lawson et al., 1990). After neonatal HI brain injury microglial 
cells become activated (Bona et al., 1999; Denker et al., 2007; McRae et al., 
1995) and produce IL-1, IL-18, ROS and proteases (Bagenholm et al., 1997; 
Hagberg et al., 1996; Hedtjarn et al., 2002; Martin et al., 1994; Piani et al., 
1992; Svedin et al., 2007).  
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Neutrophilic granulocytes are the most abundant white blood cell type and are 
a part of the innate immune system. These cells are found in the neonatal 
brain within 24 hours after brain injury in rodents (Bona et al., 1999). 
However, most of these cells stay in the intravascular compartment and 
infiltration into the brain parenchyma is limited after HI (Benjelloun et al., 
1999; Bona et al., 1999). In both adult and immature brain injury models, 
inhibition or depletion of neutrophils have been shown to be protective 
(Hudome et al., 1997; Jiang et al., 1995; Matsuo et al., 1994; Nijboer et al., 
2008).  
The complement system 
In 1895 Jules Bordet discovered “complementing” antibodies in the plasma 
that recognized and eliminated pathogens. The complement system contributes 
to the defence against pathogens (e.g bacteria, virus-infected cells and 
parasites) through release of anaphylatoxins, opsonisation and lysis of 
pathogens, stimulation of leukocyte chemotaxis and activation of leucocytes 
release of inflammatory molecules. The human complement system involves 
more than 30 cell-bound and soluble proteins. There are approximately 20 
plasma proteins which are mainly produced and secreted by macrophages, 
monocytes and hepatocytes (Alper et al., 1969; Cole et al., 1983; Einstein et al., 
1977). These soluble complement proteins are involved in the activation and 
regulation of complement proteins acting as enzymes, enzyme inhibitors, or 
enzyme cofactors. In addition, 10 cell-bound proteins regulate complement 
activation or function as receptors for proteolytic fragments generated during 
activation of a complement cascade. The complement cascade can be activated 
through three pathways, the classical pathway, the mannose-binding lectin 
pathway or the alternative pathway (Figure 1). The final step of the 
complement cascade is the terminal pathway where the formation of the 
membrane attack complex (MAC) on the surface of the target cell leads to cell 
lysis. The complement system is activated in the brain of immature rodents 
and human infants after HI (Cowell et al., 2003; Schultz et al., 2005). 
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Figure 1. Schematic overview of the three pathways activating the 
complement system and its final step the terminal pathway that leads to cell 
lysis. 
Activation of the complement system 
The classical pathway 
The complement pathway first described was the classical pathway which 
involves the three complement components C1 (C1q, C1r, C1s), C2 and C4. C1q 
is created by six identical subunits with one C-terminal globular head per 
subunit. At least two C1q globular heads have to bind either the Fc parts of an 
immunoglobulin (Ig) M molecule or two IgG molecules to activate the pathway. 
Upon activation the conformation of C1 changes and cleaves C4 into C4a and 
C4b. The thoilester bond in C4b makes it possible for the molecule to bind to a 
cell surface. C2 docks to the cell bound C4b and is cleaved by C1s into a large 
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fragment C2a and a smaller fragment C2b. The C2a complex C4b forms the 
C3-convertase, C4bC2a which cleaves C3 into C3a and C3b. Activation of the 
C1q pathway exacerbates the outcome of neonatal HI brain injury through 
mediating mitochondrial ROS formation and oxidative stress (Ten et al., 2010).  
The Mannose-binding-lectin pathway 
The mannose-binding lectin (MBL) involves the proteins MBL, C2, C4 and 
MBL associated serine proteases (MASP) 1 and 2. The MBL molecule shares 
many features with C1q (Fujita, 2002) and the classical pathway. However, the 
MBL pathway is an antibody independent pathway where MBL in the plasma 
is activated by binding to mannose on the surface of the bacteria which activate 
MASP 1 and 2 that cleaves plasma C4 and C2. The activation of MBL results 
in the formation of C3-convertase, C4bC2a that triggers the cascade. MBL can 
also remove apoptotic cells by opsonisation (Nauta et al., 2003).  
The alternative pathway 
Spontaneous hydrolysis of the thoilester bond in plasma C3 creates the C3 
(H20) molecule and activates the alternative pathway constantly. The C3 (H20) 
molecule is similar to the C3b and binds to plasma factor B which cleaves 
plasma factor D into Ba and Bb. The Bb is attached to C3 (H20) and forms C3 
(H20) Bb, the C3-convertase. C3b generated in plasma is quickly inactivated by 
the surrounding water, however if there is a pathogen near the conversion site 
C3b will form a membrane-bound C3-convertase with plasma factor Bb. The 
biological function of the Ba molecule is still unknown. 
The third complement protein (C3) 
The most abundant complement protein in the plasma is the third complement 
protein (C3), with a basal plasma concentration in humans of 1 mg/ml which 
increases during inflammation (Kushner et al., 1972). C3 is mainly produced 
and secreted by hepatocytes but is also synthesized outside the liver and is 
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composed of an alpha and a beta chain. The alpha and beta chains are attached 
to each other through a disulfide bond (Barnum et al., 1989; Fong et al., 1990; 
Janatova et al., 1986). The activation of the complement system causes the 
formation of the enzymatic complex C3-convertase.  The C3-convertase cleaves 
the C3 alpha chain and generates C3a; a small soluble anaphylatoxic fragment 
that stimulates leukocyte recruitment and activation to release pro-
inflammatory cytokines (Frank and Fries, 1991; Hugli, 1990). The larger 
fragment of the C3 molecule, C3b contains a thiolester bond which when 
exposed binds to target structures in the surrounding area and trigger the 
terminal part of the complement cascade (Sim et al., 1981). The C3 protein has 
been found as early as 15 weeks into gestation in the fetus (Adinolfi and 
Gardner, 1967), and the newborn infant C3 protein exhibits allotypic 
differences compared to their mothers C3, which demonstrate that the fetus 
produces its own C3. The C3 concentration is also very low in the infant 
compared to the mother which indicates that the C3 does not pass through the 
placenta (Propp and Alper, 1968). 
C3a is neuroprotective in vitro (van Beek et al., 2001) and induces expression 
of nerve growth factor (NGF) in human microglial cells (Heese et al., 1998).  In 
vivo, adult mice deficient in C3, C3a-receptor (C3aR) or treated with a C3aR 
antagonist show decreased neurogenesis after ischemia (Rahpeymai et al., 
2006), which confirms the positive effect of C3 and C3a on neurons. Expression 
of C3aR1, C5aR1 and C1q mRNA is induced by HI in the immature mouse 
brain (Hedtjarn et al., 2004). The role of C3 and C3a in neonatal HI is 
unknown. 
Astrocytes and reactive gliosis 
Astrocytes 
Glial cells are the most common cell type in the CNS and are divided into two 
groups: microglial and macroglial cells. Macroglial cells can be divided into 
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astrocytes and oligodendrocytes.  Traditionally astrocytes were thought to have 
a star-shaped morphology. This idea was primarily based on the commonly 
used antibody against glial fibrillary acidic protein (GFAP) used to visualize 
the cells (Eng et al., 2000) which only shows about 15% of the actual cell 
structure. More recent studies have shown that astrocytes have a bush-like 
morphology (Bushong et al., 2002).  Their bush-like morphology reaches up to 
50 µm from the cell soma (Wilhelmsson et al., 2004). Astrocytes can 
communicate with each other and with other cell types in the brain such as 
neurons, ependymal cells, oligodendrocytes and microglia. Astrocytes are found 
to maintain tight control of local ion and pH homeostasis, glucose levels and 
provide metabolic substrates (Nedergaard et al., 2003; Ransom et al., 2003). 
Also, astrocytes become activated in response to inflammation and injury, they 
protect neurons from NO toxicity (Chen et al., 2001) and can induce and 
stabilize neuronal synapses (Christopherson et al., 2005; Ullian et al., 2001). 
Intermediate filaments 
The cytoskeleton is constructed of three parts, the microtubules, actin 
filaments and intermediate filaments (IFs). Microtubules provide structural 
support and participate in intracellular transport. Actin filaments determine 
cell shape and mobility. However, the function of IFs is still not entirely 
understood although it is known that IF networks interact with microtubules 
and actin. In higher vertebrates IF proteins are often cell type specific or 
specific for the developmental stage of the cell. The astrocyte IF composition is 
dependent on the developmental and activation stage of the cell. In immature 
astrocytes IFs are composed of vimentin, synemin and nestin (Dahlstrand et 
al., 1995; Pixley and de Vellis, 1984; Sultana et al., 2000), while in mature non- 
reactive astrocytes IFs are composed of GFAP and vimentin. During astrocyte 
activation GFAP and vimentin are up-regulated and nestin re-expressed 
(Frisen et al., 1995; Lin et al., 1995). 
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 Reactive gliosis in brain injury 
In almost all CNS pathologies in humans, such as neurotrauma, stroke, 
ischemia or tumours, astrocytes in the affected area will become activated. The 
activation process, known as reactive gliosis is triggered by cell death, 
inflammatory processes and plasma proteins. The reactive astrocyte 
morphology is altered accompanied by differential expression of hundreds of 
genes compared to the non-reactive astrocyte (Eddleston and Mucke, 1993; Eng 
et al., 2000). Activated astrocytes migrate to the injured area and contribute to 
glial scar formation, which mainly consists of proteoglycans and reactive 
astrocytes. Glial scars may act as a barrier by sealing off the injured tissue 
from the healthy tissue; however, axons cannot regenerate beyond glial scars, 
which may inhibit neuronal recovery processes after damage (Silver and Miller, 
2004). Adult mice deficient in GFAP and vimentin lack intermediate filaments 
and develop less glial scarring (Pekny et al., 1999) which leads to increased 
infarction volume after ischemic injury (Li et al., 2008). However, GFAP and 
vimentin deficient mice develop worse injury immediately after entorhinal 
cortex lesion than controls but show a complete synaptic regeneration two 
weeks after injury (Wilhelmsson et al., 2004). These mice also show increased 
neurogenesis and cell proliferation in the hippocampal dentate gyrus with age 
(Larsson et al., 2004). The role that astrocyte activation and reactive gliosis 
play in neonatal HI is unknown. 
Cell proliferation and recovery in the CNS 
Neurogenesis after brain injury 
In the mammalian brain, including humans, neurons are added throughout life 
to a limited extent from neurogenic stem cells located in the subventricular 
zone (SVZ) of the lateral ventricles and the dentate gyrus subgranular zone of 
the hippocampus (Alvarez-Buylla and Lim, 2004; Curtis et al., 2007; Eriksson 
et al., 1998). Cell proliferation is highest in the young brain and every day 
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many thousands of newly proliferated neurons are produced by the dentate 
gyrus in young adult rats (Cameron and McKay, 2001). The regenerative 
abilities of the adult brain are normally limited, but after stroke, ischemia or 
trauma neural progenitor cells start to proliferate in the neurogenic zones and 
migrate to the injured area (Liu et al., 1998). At the injury site the cells 
differentiate into neurons, astrocytes and oligodendrocytes (Arvidsson et al., 
2002; Jin et al., 2003; Parent et al., 2002). The biological functionality of the 
newly born cells are not completely understood but newborn neurons in the 
hippocampus are believed to become integrated and involved in memory and 
spatial learning (Shors et al., 2001). 
Cell proliferation after injury in the developing brain 
Cell proliferation is increased in the immature brain after HI and newly born 
and surviving neurons are found in the damaged SVZ and striatum a few 
weeks after injury (Felling et al., 2006; Plane et al., 2004; Yang and Levison, 
2006). Oligodendrocyte progenitor cells are very vulnerable to HI (Back et al., 
2002; Ness et al., 2001), but proliferating immature and mature 
oligodendrocytes are found in the striatum after HI (Ong et al., 2005). Also 
newly born and surviving astrocytes and microglial cells are found in the 
hippocampus, striatum and cortex after HI in the immature brain (Ong et al., 
2005; Plane et al., 2004; Qiu et al., 2007) . 
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AIMS OF THIS THESIS 
 
The overall objective of this thesis was to investigate inflammatory 
mechanisms, recovery and cell proliferation after HI brain injury.  
 
The specific aims of the thesis were: 
 
1. To investigate the role of astrocyte activation and reactive gliosis in 
neonatal HI brain injury using GFAP and vimentin deficient mice. 
 
2. To investigate the role of complement derived peptide C3a in neonatal 
HI brain injury. 
 
3. To investigate Pavlovian fear conditioning as a method to assess brain 
injury after neonatal HI. 
 
4. To investigate the effects of lipopolysaccharide (LPS) induced systemic 
inflammation on cell proliferation in the developing brain. 
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MATERIALS AND METHODS 
Animals 
All animals were housed at Experimental Biomedicine (EBM), Sahlgrenska 
Academy, University of Gothenburg, Sweden. The mice were kept in a 12-hour 
light-dark cycle, at a constant temperature of 21°C with free access to food and 
water.  All animal experiments were approved by the local Animal Ethics 
Committee at the University of Gothenburg (ethical number 29-2006, 277-
2007, 48-2009). The GFAP and vimentin deficient (GFAP–/–Vim–/–) mice were 
bred on a mixed C57BL6/129SV/129Ola genetic background as previously 
described (Eliasson et al., 1999; Pekny et al., 1995; Pekny et al., 1999) (I). Mice 
with a C57BL/6J background were genetically modified to overexpress C3a 
under the control of a glial fibrillary acidic protein (GFAP) promoter 
(C3a/GFAP) (Boos et al., 2004) and wild type littermates were used as control 
animals (II). Wild-type C57BL/6 mice were purchased from Charles River 
Laboratories (Sultzfield, Germany) (III, IV).  
Hypoxic- ischemic brain injury model 
On postnatal day (P) 9, HI brain injury was induced as previously described 
(Hedtjarn et al., 2002; Rice et al., 1981; Sheldon et al., 1998). The mice were 
anesthetized with isoflurane (Baxter Medical, 3 % for the induction and 1.5 % 
for maintenance), in a mixture of oxygen and nitrous oxide (1:1) and the 
anesthesia duration was less than 5 minutes. Through a small incision in the 
neck, the left common carotid artery was dissected and permanently ligated 
with prolene suture (6.0). After the surgery the incision was closed and 
infiltrated with lidocaine (Xylocain®, Astra Zeneca).  The mice were returned 
to the dam for a 1 hour recovery period and were then placed in an incubator 
with humidified gas mixture of 10 % oxygen in nitrogen for 30 minutes at 36° 
C. After the hypoxic exposure the mice were returned to the dam (I, II, III).  
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Comment: This model of HI brain injury in neonatal rodents has been used 
extensively over the last 30 years (Vannucci and Vannucci, 2005). The brain 
injury is found in the cerebral hemisphere ipsilateral to the arterial occlusion 
and the degree of damage is dependent on the duration of the systemic 
hypoxia. In the present thesis a relatively short duration of hypoxia (30 min) 
has been used to induce mild injury, mainly confined to the hippocampus. 
Injections 
Bromodeoxyuridine (BrdU) (I, II, IV) 
The mice were injected intraperitoneally (i.p.) with 5-bromo-2-deoxyuridine 
(BrdU; Sigma-Aldrich; 25 mg/kg body weight), dissolved in 0.9 % NaCl saline 
twice daily from P 9 to P 12 (I, II) or twice (50 mg/kg body weight) on P 8 (24 
hours before the LPS injection) or P 11 (48 hours after the LPS injection) (IV). 
Comment: BrdU is a thymidine analogue commonly used to detect proliferating 
cells by incorporating itself into the cell DNA during the S-phase of the cell 
cycle (Nowakowski et al., 1989).   
Lipopolysaccharide (LPS) (IV) 
At P 9 or P 11, mice were injected once i.p. with lipopolysaccharide (LPS) from 
Escherichia coli (LPS O55:B5, Sigma-Aldrich) (1mg/kg body weight), dissolved 
in 0.9 % NaCl saline. 
Comment: LPS is a component of the outer membrane of Gram negative 
bacteria that is commonly used experimentally to simulate infection. LPS 
induces an innate inflammatory response systemically (Lehnardt et al., 2002; 
Wright et al., 1990) and in the brain (Eklind et al., 2006). LPS induces 
inflammation via toll-like receptors (TLRs), a type of pattern recognition 
receptors (PRRs) that are involved in recognition of pathogens in the immune 
system. TLRs are expressed on the membrane of antigen-presenting cells 
(APCs) which can present the antigens to T cells, including on microglia. 
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Microglia, the main APC in the brain, expresses several types of TLRs 
including TLR-4 (Bsibsi et al., 2002; Nguyen et al., 2002). LPS, which is 
recognized by TLR-4 (Akira et al., 2001), induces a strong inflammatory 
response in microglia (Cai et al., 2000; Dean et al., 2010; Eklind et al., 2006). 
C3a peptide (II) 
The mice were given 5 µl of a 200 nM C3a peptide solution (Complement 
Technology Inc.) in phosphate buffered saline (PBS) or only PBS via 
intracerebroventricular (i.c.v.) injection with a constant flow rate of 1 
µl/minute, using a CMA/100 microinjection pump (Bioanalytical Systems Inc.). 
Tissue preparation 
For immunohistochemical staining of paraffin sections, the animals were 
deeply anesthetized with thiopenthal (50 mg/ml; Pentothal® Sodium, Hospira) 
i.p. and intracardially perfusion fixed with 0.9 % NaCl followed by 5 % 
paraformaldehyde (Histofix, Histolab). The brains were quickly removed and 
post-fixed in 5 % paraformaldehyde and dehydrated in ethanol followed by 
xylene and embedded in paraffin. The brains were cut in 8 m thick coronal 
sections with a microtome (Rotary Microm HM 355S, Microm International). 
The sections were prepared for histochemical staining by deparaffination in 
xylene, then in alcohol and finally boiled for 10 minutes in 0.01 M citric acid 
buffer (pH 6.0) (I, II, III).  
For Quantitative real-time PCR, the animals were decapitated; the 
hippocampus, striatum and cortex from both hemispheres were dissected out 
and quickly frozen on dry-ice and stored at -80 °C (I, II).  
For all genetically modified mice and littermates, approximately 5 mm of tail 
tissue was collected and frozen for genotyping (I, II). 
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Immunohistochemistry 
Thionin/ acid fuchsin staining (II) 
For hippocampus volume evaluation the sections were stained with thionin/ 
acid fuchsin. The sections were dipped, for 4 minutes, in thionin/toluidin 
solution (1 %), then washed in dH2O and dipped in acid fuchsin (1 g/1l) 
solution, for 30 seconds. The sections were then washed again 6 times in dH2O, 
dehydrated in 95 % ethanol, 100 % ethanol, Xylene and mounted with cover 
slip.  
Immunohistochemical staining of paraffin sections (I, II, III) 
Sections were incubated in PBS with 3 % H2O2 for 10 minutes, in 2 M HCl for 1 
hour and then 30 minutes in PBS with 0.2 % Triton X-100 and 3 % BSA. For 
brain infarction area evaluation, the primary monoclonal mouse anti-
microtubule-associated protein-2 antibody (MAP-2; 1:2000; Sigma-Aldrich), 
anti-pan-neurofilament protein antibody (SMI 312; 1:2000; Covance) (I) and 
anti-NeuN antibody (1:200; Chemicon) (II, III) were used with the secondary 
horse-anti-mouse, BA-2001 antibody (1:250; Vector Laboratories). Sections 
were exposed to avidin-biotin enzyme complex ABC-Elite (Vector Laboratories) 
for 1 hour and visualized with 3, 3-diaminobenzidine (DAB; 0.5 mg/ml) and 
nickel sulphate (15 mg/ml).  
Fluorescent staining of paraffin sections (I, II) 
For fluorescent staining the following primary monoclonal antibodies were 
used: mouse anti-BrdU (1:100; Dako), mouse anti-NeuN biotin conjugated 
(1:100; Chemicon), primary polyclonal rabbit anti-S100 (1:200; Dako) and 
rabbit anti-Iba-1 (1:1000; WAKO Chemicals). The primary antibody solution 
was left on sections over night in the dark at 4˚ C. After the sections were 
washed in PBS, the secondary antibody solution was added for 1 hour at room 
temperature. The stainings were visualized using Alexa Fluor conjugated 
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secondary antibodies (1:500; Invitrogen) for matching species or Streptavidin 
Alexa Fluor 488 antibody (1:500; Invitrogen) for biotinylated primary 
antibodies. Then the sections were washed in PBS and mounted with Dako 
fluorescent mounting medium.  
Immunohistochemical staining of free floating sections (IV) 
For BrdU staining, free floating, 25 µm thick sections (IV), were incubated for 
30 minutes in 2 N hydrochloric acid at 37 °C, followed by 10 minutes in 0.1 M 
borate buffer (pH 8.5) and washed in dH2O,  for DNA dentaturation.  For 
Doublecortin (DCX) and anti-phospho-Histone H3 staining the sections were 
pretreated with sodium citrate (pH 9) for antigen retrieval.  Sections were 
incubated for 30 minutes in 0.6 % H2O2, blocked with 3 % normal donkey 
serum in 0.1 % Triton X-100, then incubated with monoclonal anti-BrdU 
(1:500; Nordic Biosite), polyclonal goat-anti DCX (1:250; Santa Cruz) or 
polyclonal phospho-Histone H3 (1:1000; Upstate Bio) overnight at 4 ºC. After 
washing the sections in tris buffered saline (TBS) they were placed in 
secondary antibody (biotinylated donkey anti-mouse antibody, biotinylated 
donkey anti-goat or biotinylated donkey anti-rabbit; 1:1000; Jackson 
ImmunoResearch Laboratories) amplified with avidin-biotin complex 
(Vectastain ABC Elite, Vector laboratories) and then visualized using a 
detection solution (DAB; 0.25 mg/ml, Saveen Biotech AB).  
Fluorescent staining of free floating sections (IV) 
Free floating sections were incubated for 72 hours at 4 ºC in primary 
antibodies, against BrdU (1:250, Nordic Biosite), NeuN (1:500, Chemicon), 
S100β (1:500, Swant) and Iba-1 (1:500 WAKO Chemicals) from different 
animal species. Sections were then washed and the staining visualized using 
Alexa Fluor conjugated secondary antibodies (1:1000; Molecular Probes, 
Eugene, OR). Sections were mounted on slides in fluorescent medium 
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containing 4', 6-diamidino-2-phenylindole (DAPI) (DAPI Pro-Long Gold anti-
fade reagent, Molecular Probes) that stains the cell nuclei. 
Histomorphological evaluation  
Images of MAP-2 (I), thionin/ acid fuchsin (II) or NeuN DAB (II, III) stained 
brain sections were obtained using a CCD camera (Olympus DP50) connected 
to a microscope (Optiphot-2, Nikon). Olympus Micro Image, v4.0 software was 
used to delineate brain regions. For paper I, MAP-2 positive and negative areas 
of contralateral and ipsilateral hemisphere were measured throughout the 
brain at a section interval of 320 μm. For Paper II, the ipsi- and contralateral 
hemisphere and hippocampus were measured in thionin/ acid fuchsin stained 
sections throughout the brain at a section interval of 320 μm. For paper III, the 
ipsi- and contralateral hippocampus and amygdala were measured in NeuN 
stained sections throughout the structures at an 80 μm interval. The infarct 
volume was assessed as the MAP-2 negative area in the ipsilateral hemisphere 
and the ipsilateral hemisphere volume was assessed as the MAP-2 negative 
area plus the ipsilateral MAP-2 positive area (I). All volumes were calculated 
according to the Cavalieri's principle where V=∑A x P x T (Svedin et al., 2007). 
Surrounding the infarct area on S100 stained sections, the length of the longest 
cellular processes of cortical astrocytes was measured using a Leica DM 6000B 
microscope with a 40x objective and Stereoinvestigator 9 (MicroBrightField 
System, Inc) as previously described (Wilhelmsson et al., 2004) (I). 
Light microscope cell counting (II, IV) 
Images of the hippocampal dentate gyrus (DG) in NeuN DAB stained sections 
with a 160 μm section interval were obtained using a light microscope (Leica 
DM 6000B; Leica Microsystems) and StereoInvestigator Software V.7 
(MicroBrightField System, Inc). Images were then analysed by the 
MetaMorph® software (Molecular Devices) (II). To determine the total number 
of BrdU, DCX and phospho-Histone H3 stained cells in the DG a stereological 
Katarina Järlestedt 
30 
 
light microscope with a motorized stage (Leica DM 6000B; Leica Microsystems) 
was used. All cell counts were performed according to stereological principles 
using StereoInvestigator Software V.7 (MicroBrightField System, Inc) (IV). 
Confocal scanning laser microscope cell counting (I, II, IV) 
Using a confocal microscope (Leica TCS SP2, Leica Microsystems, Germany) 
the number of fluorescent double stained NeuN/BrdU, Iba-1/BrdU and 
S100β/BrdU cells were counted. For paper II and IV, the total number of cells 
was counted in the hippocampal DG. For paper I and II, images from the 
subventricular zone (SVZ), through the dorsal striatum and laterally to the 
cortex were obtained and ImageJ 1.40 (Image Processing and Analysis in Java) 
software was used to analyse the Z-series stacks. The total number of double 
stained fluorescent cells was counted on 8 µm thick stacks of confocal images 
within the 450 µm x 300 µm optical fields in the respective brain regions.  
Comment: Stereology based on geometrical (Cavalieri's principle) and 
statistical principles, calculate a three-dimensional interpretation from two-
dimensional parallel sections of the brain. Throughout the thesis unbiased 
stereological methods have been used to determine cell numbers and volume of 
brain tissue. Such methods substantially reduce potential experimenter error 
and bias associated with morphometric analysis (Gundersen et al., 1988).  
Quantitative real-time PCR 
Wild-type mice were decapitated at 0 hours, 6 hours, 24 hours, 3 days, 7 days 
and 21 days after HI. The hippocampus, striatum and cortex from both 
hemispheres were dissected out, quickly frozen on dry-ice and stored at -80 ºC. 
Total RNA was extracted using RNeasy Lipid Tissue Mini Kit, including 
DNase treatment (Qiagen). RNA concentrations were measured with a 
NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies) and RNA 
integrity was checked on random samples using the Agilent 2100 bioanalyzer 
(Agilent Technologies). SuperScript III (Invitrogen) was used to performed 
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reverse transcription according to the instructions of the manufacturer using a 
mixture of 2.5 μM oligo (dT) and 2.5 μM random hexamers (both Invitrogen) as 
primers. Temperature profile for reverse transcription was 25 ºC for 5 minutes, 
50 ºC for 60 minutes, 55 ºC for 15 minutes, and 70 ºC for 15 minutes. Real-time 
PCR measurements were performed using a LightCycler 480 (Roche 
Diagnostics). Temperature profile of real-time PCR was 95 ºC for 3 minutes, 
followed by 50 cycles at 95 ºC for 20 seconds, 60 ºC for 20 seconds, and 72 ºC for 
20 seconds. Ten-microliter reactions contained iQ SYBR Green Supermix (Bio-
Rad) and 400 nM of each primer (Eurofins MWG Operon). The following primer 
sequences were used:  
C3 fwd GCCTCTCCTCTGACCTCTGG 
C3 rev AGTTCTTCGCACTGTTTCTGG 
C3a fwd TCAGTACAGTTGATG 
C3a rev TGGGCATGGAGTGGCAACTT 
C3aR1 fwd TGTTGGTGGCTCGCAGAT 
C3aR1 rev GCAATGTCTTGGGGTTGAAA 
GFAP fwd AACCGCATCACCATTCCT 
GFAP rev CGCATCTCCACAGTCTTTACC 
IL-6 fwd TTCCATCCAGTTGCCTTCTT 
IL-6 rev GGTAGCATCCATCATTTCTTTGT 
TNF-α fwd TCCCTCCAGAAAAGACACCA 
TNF-α rev CCACAAGCAGGAATGAGAA 
 
Reference genes were evaluated using the Mouse Endogenous Control Gene 
Panel (TATAA Biocenter) and NormFinder (Andersen et al., 2004). All data 
were geometrically averaged against Pgk1 and B2m. Correctly sized PCR 
products formation was confirmed by agarose gel electrophoresis (2%) for all 
assays and melting curve analysis for all samples. Data analysis was 
performed as previously described (Nolan et al., 2006; Stahlberg et al., 2005) (I, 
II). 
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Behavioural experiments 
During fear conditioning tests mice were placed in an automatic reflex 
conditioner box (Ugo Basile, Cat. No. 7530) adapted for fear conditioning to 
deliver programmable light cues and/or auditory cues and electrical stimulus to 
the floor bars of the cage. Auditory cue was programmed at 80 dB and 670 Hz 
and the electrical shock at 0.5 mA. To strengthen the association between the 
conditioned cues and the stimuli the mice were kept in the conditioning box for 
30 seconds after the shock. Freezing was defined as a complete lack of 
movement. Freezing behaviour was quantified by scoring presence or absence 
of freezing once every 10 seconds for 2 minutes and percentage of freezing was 
calculated (II, III).   
Fear conditioning with shock-paired tone and light (II, III) 
On P 49 and P 50, fear conditioning with shock-paired tone and light was 
performed. Freezing behaviour was scored on P 49 for 2 minutes for baseline, 
then the tone and light were turned on for 20 seconds, followed by a 2-second 
delay and then a 2-second shock. On P 50, freezing behaviour in the 
conditioned environment was scored for 2 minutes before the tone and light 
were presented for 30 seconds without shock and freezing behaviour was 
measured again for 2 minutes. 
Trace fear conditioning with shock-paired tone (III)   
The procedure for the trace fear conditioning test with shock-paired tone was 
the same as described above, except that the light cue was removed and the 
time interval between tone and shock was increased to a 20-second delay. 
Fear conditioning with shock-paired tone and additional contextual cues (III) 
The fear conditioning test was performed with shock-paired tone in the shock-
paired context as described above however; it was performed in a novel, non-
shock-paired context. The tone was paired with the shock and additional shock-
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paired contextual cues were added. These additional contextual cues consisted 
of a black and white striped visual cue on the back wall of the cage, lemon 
odour on filter paper under the cage floor, and a 50-mL glass beaker in the 
corner of the cage.  The day after conditioning, freezing behaviour was 
measured both in shock-paired context and in the novel context. First, freezing 
behaviour was measured in the presence of the shock-paired contextual cues 
for 2 minutes.  The shock-paired tone was then presented for 30 seconds, and 
freezing behaviour was measured for 2 minutes. Mice were returned to the 
home cage for 2 hours then placed in the novel context. The novel context cues 
were a solid black visual cue on the back wall of the cage, chocolate odour on 
filter paper in the tray under the cage floor, and a plastic sheet covering the 
metal bars on the floor of the cage. Freezing behaviour was measured for 2 
minutes then the shock-paired tone was presented for 30 seconds, and freezing 
was measured again for 2 minutes.   
Comment: Pavlovian fear conditioning is a commonly used test to investigate 
learning ability in rodents. Through teaching rodents to predict aversive events 
we can assesses hippocampal- and amygdala-dependent learning (Maren, 
2008). The animal will learn through being presented a neutral stimulus 
(becomes a conditioned stimulus, CS) such as a tone, a light or a contextual cue 
together with an aversive unconditional stimulus (US) such as a foot shock. A 
foot shock elicits freezing behaviour in fearful rodents which makes it possible 
to measure the fear reaction when presented with the CS.  
Statistics 
 The Student t-test (were normal distribution of data) or the Mann Whitney U 
test was used for statistical analysis between different time points or between 
the animal groups (GraphPad Prism). Kruskal-Wallis one way ANOVA 
followed by post hoc comparisons using a Dunn's Multiple Comparison test was 
used for all statistical analysis between more than two groups (GraphPad 
Prism). The Wilcoxon signed rank test was used to compare data from the 
Katarina Järlestedt 
34 
 
same animal. Results were given as mean ± standard deviation (SD) or mean ± 
S.E.M. Statistical differences were considered significant if p< 0.05. 
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RESULTS AND DISCUSSION 
Attenuation of reactive gliosis does not affect the hemisphere or 
infarct volume, but increases the number of surviving newborn 
neurons after HI in the developing brain (I) 
To investigate the role of reactive astrocytes in response to HI brain injury in 
the immature brain, we subjected GFAP and vimentin deficient mice (Pekny et 
al., 1999; Pekny and Nilsson, 2005) to neonatal HI. Reactive astrocytes play a 
critical role in protecting the ischemic penumbra in the adult brain (Li et al., 
2008). After HI astrocytes undergo morphological and functional changes 
starting 8 hours after the insult (Sen and Levison, 2006; Sullivan et al., 2010). 
Our data showed a near three fold up-regulation of GFAP in astrocytes starting 
as early as 24 hours after the HI insult which implies that astrocytes play a 
major part in the pathophysiological events that lead to brain injury. However, 
attenuation of reactive gliosis did not have any effect on the infarct volume or 
the volume of the injured hemisphere detected 3 days nor 22 days after HI. It 
also did not change the axonal morphology, assessed with neurofilament 
protein staining, around the injury site. The differences in response to injury 
between the immature and mature brain shows that the astrocyte involvement 
in ischemic brain injury is dependent on the developmental stage of the brain. 
HI stimulated the production of neurons in the wild-type mice and attenuation 
of reactive gliosis resulted in a higher number of newly born and surviving 
neurons after HI. GFAP–/–Vim–/– mice have earlier shown increased basal 
hippocampal neurogenesis and cell proliferation in aged animals (Larsson et 
al., 2004). Attenuated reactive gliosis also increased survival and integration of 
neuronal grafts in the CNS (Kinouchi et al., 2003; Widestrand et al., 2007). The 
absence of reactive gliosis seems to benefit neurogenesis and survival of newly 
formed neurons after HI. Interestingly, in wild-type mice undergoing reactive 
gliosis, a higher loss of astrocytes after HI occurs compared with  
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GFAP–/–Vim–/– which suggests that astrocyte reactivity makes the cell more 
vulnerable to ischemic stress. 
Increasing C3a attenuates brain injury in a mouse model of perinatal 
HI (II) 
Activation of the complement system has been thought to cause tissue damage 
in a number of ischemia models and to increase post-ischemic cerebral infarct 
volume and atrophy in adult and neonatal rats (Cowell et al., 2003; Figueroa et 
al., 2005). However, the role of different proteins of the complement system can 
vary dramatically between the immature and adult brains in ischemic injury. 
Neonatal C1q deficient mice, lacking the initial component of the classical 
pathway of complement activation, are protected against HI (Ten et al., 2005) 
but not the adult mice (Ten et al., 2010). Complement derived peptide C3a has 
anti-inflammatory effects (Kildsgaard et al., 2000) and is protective against 
excitotoxicity-induced neuronal death (van Beek et al., 2001). Using transgenic 
C3a/GFAP mice, which over-express C3a under the control of the GFAP 
promoter, we found a 10-fold increase in C3a mRNA expression in the ischemic 
hippocampus 6 hours after neonatal HI insult in the C3a/GFAP mice and a 14-
fold increase in C3a mRNA expression in the ischemic cortex at the same time 
point. The C3a/GFAP animals had a 50% larger hippocampal volume 
compared to hemisphere volume in the injured hemisphere than the wild-type 
animals 22 days after HI. Our results support the belief that C3a has 
neuroprotective functions in the injured immature brain. We found about 40% 
more NeuN positive neurons in the DG after HI. Further, we found that 
C3a/GFAP mice had a larger number of newly born and surviving 
hippocampal neurons (NeuN+BrdU+) after HI compared to wildtype animals, 
which is in agreement with previous studies showing that activation of the C3a 
receptor stimulates neurogenesis in adult mice (Rahpeymai et al., 2006). Also, 
the C3a/GFAP mice had 60% higher proliferation and survival of microglia 
and double the amount of astrocytes in the DG after HI. To further study the 
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beneficial effects of C3a we injected wildtype mice i.c.v. with C3a peptide 1 
hour after HI, which improved the HI induced memory deficit by 67%.  
Pavlovian fear conditioning is a sensitive method to detect memory 
impairments following HI injury in neonatal mice (III) 
We wanted to investigate the effect of HI on learning and memory by 
performing a fear conditioning test weeks after neonatal HI insult. Pavlovian 
fear conditioning tests have been extensively used in different animal models of 
brain injury; however, not in the commonly used neonatal HI model used in 
this thesis. In the fear conditioning test mice subjected to HI did not remember 
the association between the visual and auditory CS and the shock while the 
control mice did. The results show that the memory deficits caused by neonatal 
HI brain injury can be detected in early adulthood. However, if the time 
between the auditory CS and the shock were longer (20 seconds) none of the 
mice remembered the association between the CS and the shock. In contrast, in 
other brain injury models, in adult and neonatal rats, both trace and brief 
delay fear conditioning were affected (Chowdhury et al., 2005; Raman et al., 
2008). Also, dorsal hippocampus lesions attenuated freezing behaviour with a 
20-second trace between tone and aversive shock in adult rats (Chowdhury et 
al., 2005). Differences in experimental set-up, age of animals, and injury model 
can affect the memory and behaviour of the mice differently.  
We added more salient contextual cues to study the degree of impact the 
environment plays on learning after HI. The control mice showed enhanced 
freezing where additional cues were used both in day 1 and day 2 observations- 
the shock-paired context and the non-shock-paired context after CS 
presentation. The mice with HI injury showed impaired ability to form 
associations between the shock and the CS (visual plus auditory or auditory) 
but their ability to remember the associations between the shock and the 
shock-paired contextual cues was not affected. It has been shown that both fear 
conditioning to discrete shock-paired stimuli such as tone or light and to 
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contextual cues are amygdala-dependent and that the dorsal hippocampus has 
been associated with contextual fear conditioning (Kim and Fanselow, 1992; 
Maren et al., 1997; Phillips and LeDoux, 1992). Our results showed a reduction 
in both amygdala and hippocampal volume in the mice exposed to neonatal HI 
injury and the memory impairment of these animals may be the consequence of 
simultaneous injury to hippocampus and amygdala.  
LPS induced inflammation has different effects on cell survival and 
proliferation in the immature hippocampus (IV) 
Lipopolysaccharide is a strong inducer of inflammation and affects immune 
cells in the brain of rodents at different ages (Qin et al., 2007; Spencer et al., 
2007; Wang et al., 2007). Inflammation decreases cell proliferation and 
neurogenesis in the prenatal and adult brain (Cui et al., 2009; Ekdahl et al., 
2003; Monje et al., 2003). The effect of inflammation on neurogenesis might be 
mediated through toll-like receptors (TLR) in the adult brain, including the 
LPS receptor TLR-4 (Rolls et al., 2007). Our results showed that LPS had a 
strong negative effect on cells born after, but not on cells born during or before 
LPS exposure. LPS seems to affect hippocampal cell survival rather than cell 
proliferation. Perhaps newborn cells that have completed cell division cycle are 
more prone to survive inflammation. We did not find any effect on numbers of 
immature neurons or cell proliferation 30 days after LPS exposure which also 
points to LPS having an effect on cell survival rather than proliferation. 
Increased cell death in the dentate gyrus, but no effect on cell proliferation 
after LPS has been shown in the adult brain (Bastos et al., 2008) which 
supports our results. Astrocytes in the hippocampus actively regulate 
neurogenesis by promoting proliferation and differentiation of neural stem cells 
(Song et al., 2002). It has been previously shown that LPS exposure reduces the 
number of astrocytes in fetal sheep (Mallard et al., 2003). Our results showed 
reduced survival of both astrocytes and neurons born two days after LPS 
administration. We did not find any difference in number of newborn or 
resident microglia in the granule cell layer two days after LPS administration 
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and the number of cells was very low. Perhaps microglia are more prominent in 
other regions of the hippocampus than the granule cell layer which was seen in 
a study where E coli injection lead to increased number of resident microglia 
and proliferating microglia in the CA1 and CA3 region of the hippocampus, but 
not in the dentate gyrus (Bland et al., 2010). Two days after LPS exposure 
might also be too early to detect microglia proliferation. 
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CONCLUDING REMARKS 
 
 In this model of P 9 HI injury the intermediate filaments GFAP and 
vimentin do not affect injury volume, but the reduction of reactive 
gliosis increases the number of surviving newly born neurons in the 
ischemic cortex. In contrast, to the adult brain, reactive gliosis does not 
appear to play a major role in the protection of the neonatal brain after 
HI injury. Further investigation into injury mechanisms mediated by 
other inflammatory cell types in the immature brain is needed. 
 We have shown that neonatal HI leads to increased C3a mRNA 
expression, and that over expression of C3a peptide reduces brain 
injury; coincident with increased cell proliferation and survival in the 
hippocampal DG. Additionally, supplementing C3a improves memory 
function after neonatal HI injury. More research is needed to 
understand how enhancing an inherent immunomodulatory pathway, 
such as complement/ C3a could be used as a potential therapeutic 
target in the future. 
 For future studies we wanted to evaluate an effective behavioural test 
to assess neurological outcome and memory function after brain injury. 
Neonatal HI reduces the volume of the hippocampus and the amygdala 
and Pavlovian fear conditioning is a sensitive and effective method to 
assess learning impairment in this injury model. 
 Finally, we demonstrated that LPS exposure on P 9 reduces survival of 
neurons and astrocytes in the developing brain. Since infection is 
associated with poorer neurological outcome, these results suggest 
early targeting treatments that increase cell survival may be important 
in developing effective neuroprotective strategies to improve infant 
outcome.  
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